BioNTech SE (ETR:22UA)
78.55
-0.50 (-0.63%)
Last updated: Aug 3, 2026, 9:24 AM CET
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
€359,319
Profits / Employee
€160,395
Market Cap
19.91B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Fresenius Medical Care AG | 108,165 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| Fielmann Group AG | 18,928 |
| Sartorius Aktiengesellschaft | 14,279 |
| Ottobock SE & Co. KGaA | 10,365 |
BioNTech SE News
- 4 days ago - EC authorizes Pfizer, BioNTech XFG-adapted COVID-19 vaccine in EU - TheFly
- 4 days ago - European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union - Business Wire
- 12 days ago - BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026 - GlobeNewsWire
- 25 days ago - BioNTech price target lowered to $119 from $126 at Morgan Stanley - TheFly
- 4 weeks ago - BioNTech held buyer talks over four German sites set to close, Handelsblatt reports - Reuters
- 6 weeks ago - Moderna interested in Germany production, sees opportunity in BioNTech closures, says CEO - Reuters
- 2 months ago - BioNTech, Bristol announce interim Phase 2 data from Rosetta Lung-02 trial - TheFly
- 2 months ago - Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial - GlobeNewsWire